Cigna announces new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs
1. Cigna's Evernorth secures deals to lower GLP-1 drug prices. 2. Capped out-of-pocket costs at $200 encourage drug coverage. 3. Current coverage could reduce costs by up to 20%. 4. CVS chooses Novo's Wegovy over Lilly's Zepbound for preferred coverage. 5. Medicare drug negotiations may impact Lilly's market strategy by 2027.